Clinical Oncology Next Generation Sequencing Market

Clinical Oncology Next-generation Sequencing Market: Launch of Low-cost Sequencing Platforms to Accelerate Adoption: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Ask The Analyst Customization Available Request Methodology
clinical oncology next generation sequencing market snapshot

Clinical Oncology Next-Generation Sequencing Market - Key Research Findings

  1. Global clinical oncology next-generation sequencing market size in 2018– Over US$ 200 Mn 

  1. The clinical oncology next-generation sequencing market is expected to observe a CAGR of 17.0% over 2019-2029. 

  1. North America and Europe are expected to remain the largest regional markets for clinical oncology next-generation sequencing 

  • The presence of well-established healthcare infrastructure in the U.S. is one of the major factors contributing to the growth of the clinical oncology next-generation sequencing market. 

  1. North America is expected to exhibit a high growth potential for the clinical oncology next-generation sequencing market 

  • Increasing healthcare awareness is expected to increase the boost the clinical oncology next-generation sequencing market. 

    clinical oncology next generation sequencing market

Top 3 Factors Shaping the Clinical Oncology Next-Generation Sequencing Market

  • Increasing prevalence of cancers

Increasing prevalence of cancer is a major factor responsible for the growth of the clinical oncology next-generation sequencing market. Increasing biomedical research using clinical oncology next-generation sequencing is expected to create a conducive atmosphere for the growth of the clinical oncology next-generation sequencing market in the near future. According to WHO, cancer is the second leading cause of death globally, and was responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths are caused by cancer. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths.

  • Increasing government funding for life science projects is expected to boost the clinical oncology next-generation sequencing market

Government funding for life science research is expected to result in the availability of funding for the undertaking of various clinical oncology next-generation sequencing projects, as well as for the employment of the required personnel. This is expected to contribute to the growth of the clinical oncology next-generation sequencing market.

The various sources of research and development spending include governments, private funding, and commercial organizations. Different life science projects have been undertaken, which has resulted in the employment of various personnel, and this is likely to fuel the growth of the clinical oncology next-generation sequencing market.

  • Declining prices of sequencing are highly likely to contribute to the growth of the clinical oncology next-generation sequencing market

The characteristic features of clinical oncology next-generation sequencing technology are implicated widely in research and academic institutes. Clinical oncology next-generation sequencing techniques offer a high percentage of reads and cost-effectiveness per read. This has been possible due to the launch of low-cost sequencing platforms in the market. This can increase the overall growth of the clinical oncology next-generation sequencing market. Various market players, such as Roche and Illumina, have introduced sequencing techniques that have reduced the cost of clinical oncology next-generation sequencing.

Clinical Oncology Next-Generation Sequencing Market Structure Analysis

  • In the global clinical oncology next-generation sequencing market, tier 1 companies hold a revenue share of more than 60%.

  • Most of the key players in the clinical oncology next-generation sequencing market focus on developing innovative products. They also focus on partnerships and collaborations to expand their product portfolio.

FMI has conducted a study on the clinical oncology next-generation sequencing through the analysis and forecast of the clinical oncology next-generation sequencing market in its publication titled ‘Clinical Oncology Next-Generation Sequencing Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029.’ This report on the clinical oncology next-generation sequencing market covers the various key factors influencing the demand and supply of clinical oncology next-generation sequencing over the next several years. This report consists of the drivers, restraints, various market trends, and opportunities for participants in the clinical oncology next-generation sequencing market.

A study has been done on the various technologies of next-generation sequencing and how each technology differs from other technologies. The report consists of the ongoing trends in the market, and the various opportunities for the significant growth of the clinical oncology next-generation sequencing market.

The report consists of the various strategies adopted by the key manufacturers in the clinical oncology next-generation sequencing market. International collaborations are one of the main strategies adopted by the key manufacturers in the market. Nowadays, manufacturers are trying to develop new error-free sequencing technologies to obtain better sequencing results.

The report also focuses on the various macro-economic factors that are affecting the overall growth of the market. Some of the important macro-economic factors affecting the growth of the market include economic growth & inflation, and growing biomedical research in emerging markets. Changing biomedical and biotechnological demographics in emerging economies, such as China, India, Brazil, and South Africa, are expected to fuel the growth opportunities for medical device manufacturers. Public as well as private healthcare expenditure in these countries is expected to witness high growth, which is, in turn, expected to attract the manufacturers in these markets.

The report also contains key regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa. Various trends in these regions have been covered in this report. The market attractiveness index of the products for all the regions have been covered in this report. The report also contains the market scenario of the different countries covered by each region.

The report also contains the forecast factors that impact the growth of the market. There forecast factors are expected to increase the growth of the clinical oncology next-generation sequencing market. The impact analysis of the forecast factors has been covered in the report.

The regulatory scenario for the next-generation sequencing used for oncology has been covered in this report. The profiles of various companies associated with the clinical oncology next-generation treatment market has also been included in this report, in addition to the competition landscape of various key players in the clinical oncology next-generation sequencing market.

Various key players in the clinical oncology next-generation sequencing market manufacturer several products for the sequencing of DNA. The strengths and weakness of various companies have been covered in the report.

The report also focuses on the research methodology being adopted by researchers for the estimation of the clinical oncology next-generation sequencing market in different geographies.

Global Clinical Oncology Next-Generation Sequencing Market: Segmentation

Clinical Oncology Next-Generation Sequencing Market Analysis by Product Type

  • Sequencing Platforms

  • Sequencing Products

  • Kits and Reagents

  • Services

Clinical Oncology Next-Generation Sequencing Market Analysis by Technology

  • Ion Semiconductor Sequencing

  • Pyro-Sequencing

  • Synthesis Sequencing (SBS)

  • Real Time Sequencing (SMRT)

  • Ligation Sequencing

  • Reversible Dye Termination Sequencing

  • Nano-Pore Sequencing

Clinical Oncology Next-Generation Sequencing Market Analysis by Application

  • Whole Tumor Genome Sequencing

  • Whole Tumor Exome Sequencing

  • Targeted Tumor Genome Profiling

  • Tumor Transcriptome Sequencing

  • Tumor-normal Comparisons

  • Others

Clinical Oncology Next-Generation Sequencing Market Analysis by End User

  • Hospital Laboratories

  • Clinical Research Organizations

  • Diagnostic Laboratories

  • Others 

Clinical Oncology Next-Generation Sequencing Market Analysis by Region

  • North America

  • Latin America

  • Europe

  • East Asia

  • South Asia

  • Oceania

  • Middle East & Africa

Clinical Oncology Next Generation Sequencing Market Reports - Table of Contents

1. Executive Summary

       1.1. Global Market Outlook

       1.2. Analysis and Recommendations

2. Market Overview

       2.1. Market Coverage / Taxonomy

       2.2. Market Definition / Scope / Limitations

3. Market Background

       3.1. Macro-Economic Factors

       3.2. Forecast Factors - Relevance & Impact

       3.3. Market Dynamics

              3.3.1. Drivers

              3.3.2. Restraints

              3.3.3. Opportunities

              3.3.4. Trends

4. Key Success Factors

       4.1. Cancer Epidemiology, By Region

       4.2. Key Regulations 

5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Value (US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

       5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

       5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

              5.2.1. Y-o-Y Growth Trend Analysis

              5.2.2. Absolute $ Opportunity Analysis

6. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Component

       6.1. Introduction

       6.2. Historical Market Size (US$ Mn) Analysis By Component, 2014-2018

       6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Component, 2019-2029

              6.3.1. Sequencing Platforms

              6.3.2. Sequencing Products

              6.3.3. Kits and Reagents

              6.3.4. Services

       6.4. Market Attractiveness Analysis By Component

7. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Technology

       7.1. Introduction

       7.2. Historical Market Size (US$ Mn) and Volume Analysis By Technology, 2014-2018

       7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2018 - 2018

              7.3.1. Ion Semiconductor Sequencing

              7.3.2. Pyro-Sequencing

              7.3.3. Synthesis Sequencing (SBS)

              7.3.4. Real Time Sequencing (SMRT)

              7.3.5. Ligation Sequencing

              7.3.6. Reversible Dye Termination Sequencing

              7.3.7. Nano-Pore Sequencing

              7.3.8. Others

       7.4. Market Attractiveness Analysis By Application

8. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Application

       8.1. Introduction

       8.2. Historical Market Size (US$ Mn) By Application, 2014-2018

       8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2018 - 2018

              8.3.1. Whole Tumor Genome Sequencing

              8.3.2. Whole Tumor Exome Sequencing

              8.3.3. Targeted Tumor Genome Profiling

              8.3.4. Tumor Transcriptome Sequencing

              8.3.5. Tumor-normal Comparisons

              8.3.6. Others

       8.4. Market Attractiveness Analysis By Application

9. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by End User

       9.1. Introduction

       9.2. Historical Market Size (US$ Mn) By End User, 2014-2018

       9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2018 - 2018

              9.3.1. Hospital Laboratories

              9.3.2. Clinical Research Organizations

              9.3.3. Diagnostic Laboratories

              9.3.4. Others

       9.4. Market Attractiveness Analysis By End User

10. Global Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029, by Region

       10.1. Introduction

       10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

       10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018

              10.3.1. North America

              10.3.2. Latin America

              10.3.3. Europe

              10.3.4. East Asia

              10.3.5. South Asia

              10.3.6. Oceania

              10.3.7. MEA

       10.4. Market Attractiveness Analysis By Region

11. North America Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       11.1. Introduction

       11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

       11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

              11.3.1. By Country

                       11.3.1.1. U.S.

                       11.3.1.2. Canada

              11.3.2. By Component

              11.3.3. By Technology

              11.3.4. By Application

              11.3.5. By End User

       11.4. Market Attractiveness Analysis

12. Latin America Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       12.1. Introduction

       12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

       12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

              12.3.1. By Country

                       12.3.1.1. Brazil

                       12.3.1.2. Mexico

                       12.3.1.3. Rest of Latin America

              12.3.2. By Component

              12.3.3. By Technology

              12.3.4. By Application

              12.3.5. By End User

       12.4. Market Attractiveness Analysis

13. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       13.1. Introduction

       13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

       13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

              13.3.1. By Country

                       13.3.1.1. Germany

                       13.3.1.2. Italy

                       13.3.1.3. France

                       13.3.1.4. U.K.

                       13.3.1.5. Spain

                       13.3.1.6. BENELUX

                       13.3.1.7. Russia

                       13.3.1.8. Rest of Europe

              13.3.2. By Component

              13.3.3. By Technology

              13.3.4. By Application

              13.3.5. By End User

       13.4. Market Attractiveness Analysis

14. East Asia Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       14.1. Introduction

       14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

       14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

              14.3.1. By Country

                       14.3.1.1. C China

                       14.3.1.2. Japan

                       14.3.1.3. South Korea

              14.3.2. By Component

              14.3.3. By Technology

              14.3.4. By Application

              14.3.5. By End User

       14.4. Market Attractiveness Analysis

15. South Asia Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       15.1. Introduction

       15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

       15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

              15.3.1. By Country

                       15.3.1.1. India

                       15.3.1.2. Thailand

                       15.3.1.3. Indonesia

                       15.3.1.4. Malaysia

                       15.3.1.5. Rest of South Asia

              15.3.2. By Component

              15.3.3. By Technology

              15.3.4. By Application

              15.3.5. By End User

       15.4. Market Attractiveness Analysis

16. Oceania Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       16.1. Introduction

       16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

       16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

              16.3.1. By Country

                       16.3.1.1. Australia

                       16.3.1.2. New Zealand

              16.3.2. By Component

              16.3.3. By Technology

              16.3.4. By Application

              16.3.5. By End User

       16.4. Market Attractiveness Analysis

17. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       17.1. Introduction

       17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

       17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

              17.3.1. By Country

                       17.3.1.1. GCC Countries

                       17.3.1.2. Turkey

                       17.3.1.3. Northern Africa

                       17.3.1.4. South Africa

                       17.3.1.5. Rest of Middle East and Africa

              17.3.2. By Component

              17.3.3. By Technology

              17.3.4. By Application

              17.3.5. By End User

       17.4. Market Attractiveness Analysis

18. Emerging Countries Clinical Oncology Next Generation Sequencing (NGS) Market Analysis 2014-2018 and Forecast 2019-2029

       18.1. Introduction

              18.1.1. Market Value Proportion Analysis, By Key Countries

              18.1.2. Global Vs. Country Growth Comparison

       18.2. China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

              18.2.1. Introduction

              18.2.2. Market Value Proportion Analysis by Market Taxonomy

                       18.2.2.1. By Component

                       18.2.2.2. By Technology

                       18.2.2.3. By Application

                       18.2.2.4. By End User

       18.3. South Korea Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

              18.3.1. Introduction

              18.3.2. Market Value Proportion Analysis by Market Taxonomy

                       18.3.2.1. By Component

                       18.3.2.2. By Technology

                       18.3.2.3. By Application

                       18.3.2.4. By End User

       18.4. India Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

              18.4.1. Introduction

              18.4.2. Market Value Proportion Analysis by Market Taxonomy

                       18.4.2.1. By Component

                       18.4.2.2. By Technology

                       18.4.2.3. By Application

                       18.4.2.4. By End User

19. Market Structure Analysis

       19.1. Market Analysis by Tier of Companies

       19.2. Market Share Analysis of Top Players

20. Competition Analysis

       20.1. Competition Dashboard

       20.2. Competition Deep Dive

              20.2.1. Illumina, Inc.

                       20.2.1.1. Overview

                       20.2.1.2. Product Portfolio

                       20.2.1.3. Sales Footprint

                       20.2.1.4. Analysis Commentary

              20.2.2. F. Hoffmann-La Roche Ltd

              20.2.3. Oxford Nanopore Technologies

              20.2.4. Agilent Technologies

              20.2.5. Thermo Fisher Scientific Inc

              20.2.6. PerkinElmer, Inc.,

              20.2.7. Becton, Dickinson and Company

              20.2.8. QIAGEN N.V.

              20.2.9. Pacific Biosciences of California, Inc.

              20.2.10. BGI Group

              20.2.11. Takara Bio, Inc

              20.2.12. Creative-Biolabs

              20.2.13. Mogene LC

21. Assumptions and Acronyms Used

22. Research Methodology

Clinical Oncology Next Generation Sequencing Market Reports - List of Tables

Table 01: Global Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 02: Global Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 03: Global Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 04: Global Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 05: Global Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Region

Table 06: North America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 07: North America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 08: North America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 09: North America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 10: North America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 11: Latin America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 12: Latin America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 13: Latin America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 14: Latin America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 15: Latin America Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 16: Europe Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 17: Europe Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 18: Europe Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 19: Europe Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 20: Europe Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 21: East Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 22: East Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 23: East Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 24: East Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 25: East Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 26: South Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 27: South Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 28: South Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 29: South Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 30: South Asia Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 31: Oceania Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 32: Oceania Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 33: Oceania Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 34: Oceania Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 35: Oceania Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 36: MEA Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Country

Table 37: MEA Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 38: MEA Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 39: MEA Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 40: MEA Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 41: China Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 42: China Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 43: China Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 44: China Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 45: South Korea Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 46: South Korea Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 47: South Korea Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 48: South Korea Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Table 49: India Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Product Type

Table 50: India Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Technology

Table 51: India Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By Application

Table 52: India Clinical Oncology Next Generation Sequencing Market Value (US$) Analysis 2014-2018 and Forecast 2019-2029, By End User

Clinical Oncology Next Generation Sequencing Market Reports - List of Figures

Figure 01: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 02: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 03: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 04: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 05: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Region (2019)

Figure 06: Global Clinical Oncology Next Generation Sequencing Market Size and Y-o-Y, 2014–2018

Figure 07: Global Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029

Figure 08: Global Clinical Oncology Next Generation Sequencing Market Absolute $ Opportunity, 2018–2029

Figure 09: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis (%) By Product Type, 2019 & 2029

Figure 10: Global Clinical Oncology Next Generation Sequencing Market Y-o-Y Growth (%) Analysis, By Product Type, 2019–2029

Figure 11: Global Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 12: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis (%) By Technology, 2019 & 2029

Figure 13: Global Clinical Oncology Next Generation Sequencing Market Y-o-Y Growth (%) By Technology, 2019–2029

Figure 14: Global Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 15: Global Clinical Oncology Next Generation Sequencing Market Value Share Analysis (%) By Application, 2019 & 2029

Figure 16: Global Clinical Oncology Next Generation Sequencing Market Y-o-Y Growth (%) By Application, 2019–2029

Figure 17: Global Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 18: Global Clinical Oncology Next Generation Sequencing Market Share Analysis (%) By End User, 2019 & 2029

Figure 19: Global Clinical Oncology Next Generation Sequencing Market Y-o-Y Growth (%) By End User, 2019–2029

Figure 20: Global Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 21: Global Clinical Oncology Next Generation Sequencing Market Share Analysis (%) By Region, 2019 & 2029

Figure 22: Global Clinical Oncology Next Generation Sequencing Market Y-o-Y Growth (%) By Region, 2019–2029

Figure 23: Global Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Region

Figure 24: North America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 25: North America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 26: North America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 27: North America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 28: North America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Country (2019)

Figure 29: North America Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Analysis, 2014-2018

Figure 30: North America Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019-2029

Figure 31: North America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 32: North America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 33: North America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 34: North America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 35: North America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Country

Figure 36: Latin America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 37: Latin America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 38: Latin America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 39: Latin America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 40: Latin America Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Country (2019)

Figure 41: Latin America Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Analysis, 2014-2018

Figure 42: Latin America Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019-2029

Figure 43: Latin America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 44: Latin America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 45: Latin America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 46: Latin America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 47: Latin America Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Country

Figure 48: Europe Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 49: Europe Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 50: Europe Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 51: Europe Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 52: Europe Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Country (2019)

Figure 53: Europe Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Analysis, 2014-2018

Figure 54: Europe Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019-2029

Figure 55: Europe Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 56: Europe Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 57: Europe Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 58: Europe Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 59: Europe Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Country

Figure 60: East Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 61: East Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 62: East Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 63: East Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 64: East Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Country (2019)

Figure 65: East Asia Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Analysis, 2014-2018

Figure 66: East Asia Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019-2029

Figure 67: East Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 68: East Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 69: East Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 70: East Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 71: East Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Country

Figure 72: South Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 73: South Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 74: South Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 75: South Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 76: South Asia Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Country (2019)

Figure 77: South Asia Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Analysis, 2014-2018

Figure 78: South Asia Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019-2029

Figure 79: South Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 80: South Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 81: South Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 82: South Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 83: South Asia Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Country

Figure 84: Oceania Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 85: Oceania Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 86: Oceania Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 87: Oceania Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 88: Oceania Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Country (2019)

Figure 89: Oceania Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Analysis, 2014-2018

Figure 90: Oceania Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019-2029

Figure 91: Oceania Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 92: Oceania Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 93: Oceania Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 94: Oceania Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 95: Oceania Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Country

Figure 96: MEA Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Product Type (2019)

Figure 97: MEA Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Technology (2019)

Figure 98: MEA Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Application (2019)

Figure 99: MEA Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by End User (2019)

Figure 100: MEA Clinical Oncology Next Generation Sequencing Market Value Share Analysis, by Country (2019)

Figure 101: MEA Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Analysis, 2014-2018

Figure 102: MEA Clinical Oncology Next Generation Sequencing Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019-2029

Figure 103: MEA Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Product Type

Figure 104: MEA Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Technology

Figure 105: MEA Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Application

Figure 106: MEA Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By End User

Figure 107: MEA Clinical Oncology Next Generation Sequencing Market Attractiveness Analysis, By Country

Figure 108: Global Oncology Next Generation Sequencing Market Value Proportion Analysis, By Emerging Countries, 2019

Figure 109: Oncology Next Generation Sequencing Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2018-2028